 The main objective of the study is evaluation of the safety and tolerability of OpRegen - human embryonic stem cell-derived retinal pigment epithelial RPEcells. The study will also include initial exploration of the ability of transplanted OpRegen cells to engraft, survive, and moderate disease progression. 